tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Soumit Roy, 18 are a BUY (72%), 7 are a HOLD (28%).
Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 21.67% that have a potential upside of 36.9% achieved within 59 days.
Soumit Roy’s has documented 43 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DCPH, Deciphera Pharmaceuticals LLC at 29-Apr-2024.
Analyst best performing recommendations are on AVEO (AVEO PHARMACEUTICALS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 4/11/2024. The price target of $10 was fulfilled within 196 days with a profit of $6.15 (159.74%) receiving and performance score of 8.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$26
$0.41 (1.60%)
$9
6 months 9 days ago
(30-Apr-2024)
3/10 (30%)
$0.73 (2.89%)
235
Buy
$23
6 months 9 days ago
(30-Apr-2024)
4/6 (66.67%)
$8.58 (59.50%)
353
Buy
$22
6 months 9 days ago
(30-Apr-2024)
2/3 (66.67%)
$2.24 (11.34%)
67
Buy
$25.6
$0.01 (0.04%)
6 months 10 days ago
(29-Apr-2024)
0/3 (0%)
$10.95 (74.74%)
Hold
$14
$-11.59 (-45.29%)
$52
11 months 19 days ago
(20-Nov-2023)
4/4 (100%)
$1.66 (13.45%)
92
What Year was the first public recommendation made by Soumit Roy?
